End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.34 CNY | -4.84% | +3.50% | -34.52% |
Business Summary
Number of employees: 617
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Molecular Building Blocks Heterocyclic Compounds
43.2
%
| 379 | 45.5 % | 472 | 43.2 % | +24.41% |
Molecular Building Blocks Benzene Ring Compounds
27.1
%
| 219 | 26.3 % | 296 | 27.1 % | +35.05% |
Molecular Building Blocks Aliphatic Compounds
16.3
%
| 137 | 16.4 % | 178 | 16.3 % | +29.86% |
Catalysts and Ligands
9.7
%
| 77 | 9.2 % | 106 | 9.7 % | +37.23% |
Active Small Molecule Compounds
3.7
%
| 22 | 2.6 % | 41 | 3.7 % | +88.42% |
Other
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | +8.06% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
51.0
%
| 406 | 48.6 % | 557 | 51.0 % | +37.36% |
China
49.0
%
| 428 | 51.4 % | 535 | 49.0 % | +24.88% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lan Dai
CEO | Chief Executive Officer | 52 | 07-03-31 |
Mei Cai
CHM | Chairman | 39 | 12-04-30 |
Rong Hao Li
CTO | Chief Tech/Sci/R&D Officer | 41 | 08-03-31 |
Chao Wang
CTO | Chief Tech/Sci/R&D Officer | 41 | 08-02-29 |
Tao Li
BRD | Director/Board Member | 38 | 19-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Meng
BRD | Director/Board Member | 58 | 23-10-12 |
Tao Li
BRD | Director/Board Member | 38 | 19-05-31 |
Lan Dai
CEO | Chief Executive Officer | 52 | 07-03-31 |
Chao Wang
BRD | Director/Board Member | 41 | 18-02-28 |
Yun Zhao
BRD | Director/Board Member | 44 | 14-02-28 |
Zhi Chang Liu
BRD | Director/Board Member | 44 | 23-10-12 |
Yong Ping Tao
BRD | Director/Board Member | 61 | 23-10-12 |
Mei Cai
CHM | Chairman | 39 | 12-04-30 |
Rong Hao Li
CTO | Chief Tech/Sci/R&D Officer | 41 | 18-01-31 |
Jiang Bo Wan
BRD | Director/Board Member | 39 | 23-10-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,882,948 | 27,425,196 ( 30.18 %) | 0 | 30.18 % |
Company contact information
Bide Pharmatech Co., Ltd.
6/F, Building 3 999 Xiangyin Road
200433, Shanghai
+
http://www.bidepharmatech.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.52% | 457M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- 688073 Stock
- Company Bide Pharmatech Co., Ltd.